S

Spruce Biosciences
D

SPRB

0.42100
USD
-0.00
(-0.33%)
مغلق
حجم التداول
1,100
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
17,388,394
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Spruce Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).